Publications in collaboration with researchers from Centro de Investigacion Biomedica en Red de Salud Mental (12)

2024

  1. Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia

    Schizophrenia Research, Vol. 270, pp. 260-272

2023

  1. Human Breast Milk microRNAs, Potential Players in the Regulation of Nervous System

    Nutrients, Vol. 15, Núm. 14

  2. Proteomic analysis of exosomes derived from human mature milk and colostrum of mothers with term, late preterm, or very preterm delivery

    Analytical Methods, Vol. 15, Núm. 37, pp. 4905-4917

2022

  1. Efficacy of the Therapeutic Game “Trisquel” in the Treatment of Patients With Substance-Related Disorders Randomized Clinical Study

    Frontiers in Psychiatry, Vol. 13

2021

  1. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis

    Early Intervention in Psychiatry, Vol. 15, Núm. 6, pp. 1584-1594

  2. Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program: Pilot study

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 125-138

2020

  1. A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine

    Frontiers in Psychiatry, Vol. 11

  2. Mania as Debut of Cushing's Syndrome

    Case Reports in Psychiatry, Vol. 2020

2019

  1. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

  2. Evaluación de la adherencia al tratamiento con antipsicóticos inyectables de liberación prolongada dentro de un programa de seguimiento farmacoterapéutico

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 43, Núm. 6, pp. 177-181

  3. Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 92-105

2017

  1. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: Results of a randomized, double-blind clinical trial

    BMC Psychiatry, Vol. 17, Núm. 1